CLOV — CLOVER HEALTH INVESTMENTS, CORP. /DE
—
Nasdaq ·
Financials ·
Insurance ·
CIK 1801170 ·
Last close
$4.11
Market Cap
$1.79B
52W High
$5.59
52W Low
$3.45
ADV30
4,372,624
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 749,189,000 | 159,541,000 | 27,334,000 | 27,334,000 | 697,728,000 | 173,265,000 | 358,302,000 |
| Dec 2025 | 487,707,000 | 74,208,000 | -49,319,000 | -49,320,000 | 541,011,000 | 78,301,000 | 232,307,000 |
| Sep 2025 | 496,650,000 | 73,177,000 | -24,377,000 | -24,377,000 | 559,659,000 | 190,055,000 | 218,727,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$57,254,000
Investing CF
$-9,922,000
Financing CF
$-29,506,000
CapEx
$-2,712,000
Dividends Paid
—
Buybacks
$-31,135,000
EPS Diluted TTM
$-0.05
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,261,018,000
Inventory
—
Receivables
$202,689,000
ST Investments
$30,278,000
EBIT TTM
$-56,941,000
Pretax Income TTM
$-56,941,000
Interest Exp TTM
$0
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,475,912,960
EBITDA
$-17,956,000
Free Cash Flow
$69,048,376
Enterprise Value
$1,939,952,256
Total Cash
$243,100,000
Total Debt
$0
Shares Out
435,441,337
Trailing EPS
$-0.05
Book Value
$0.71
ROE
-5.1%
ROA
-1.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,924,308,000 | -85,529,000 | -85,549,000 | 541,011,000 | 232,307,000 | — | -66,934,000 |
| Dec 2024 | 1,371,131,000 | -45,461,000 | -43,009,000 | 580,742,000 | 239,599,000 | — | 34,845,000 |
| Dec 2023 | 1,260,543,000 | -179,563,000 | -213,361,000 | 570,671,000 | 284,277,000 | — | -144,662,000 |
| Dec 2022 | 1,096,552,000 | -286,664,000 | -339,567,000 | 808,620,000 | 451,733,000 | — | -203,926,000 |
TTM Snapshot
Revenues TTM
$1,920,994,000
NetIncome TTM
$-201,792,000
OpCashFlow TTM
$0
Assets (Latest)
$580,742,000
Forward EPS
$0.15
Max Pain — expiry 2026-08-28
max pain strike: $4.50 · spot: $4.11 · call oi: 5,922 · put oi: 14,417
Expected Move to 2026-08-28:
±$0.23
(5.60%) —
implied range
$3.88 –
$4.34
· ATM straddle on $4.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GSHD | Goosehead Insurance, Inc. | $1.74B | $73.00 | — |
| KMPR | KEMPER Corp | $1.63B | $27.66 | — |
| AXS-PE | AXIS CAPITAL HOLDINGS LTD | $1.55B | $18.53 | — |
| HMN | HORACE MANN EDUCATORS CORP /DE/ | $2.07B | $51.20 | — |
| SAFT | SAFETY INSURANCE GROUP INC | $1.52B | $103.75 | — |
News headlines (Yahoo Finance, 1h cache)
Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?
2026-08-14 12:09 · Yahoo
The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call
2026-08-14 09:33 · Yahoo
Clover Health (CLOV) Q2 2026 Earnings Call Transcript
2026-08-13 01:14 · Yahoo
Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth
2026-08-11 15:05 · Yahoo
Clover Health Investments Q2 Earnings Call Highlights
2026-08-06 00:04 · Yahoo
Clover Health’s (NASDAQ:CLOV) Q2 CY2026 Sales Top Estimates, Stock Jumps 10.3%
2026-08-05 21:12 · Yahoo
Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.
2026-07-31 12:41 · Yahoo
Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
2026-07-22 20:05 · Yahoo
Clover Health Investments, Corp. Q2 2026 Earnings Call Summary
2026-08-06 12:30 · Yahoo
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
2026-08-24 13:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.